GIA
WST icon

GHP Investment Advisors’s West Pharmaceutical WST Stock Holding History

GHP Investment Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.7K Hold
41
– – ﹤0.01% 758
2026
Q1 		$10.3K Hold
41
– – ﹤0.01% 807
2025
Q4 		$11.3K Hold
41
– – ﹤0.01% 720
2025
Q3 		$10.8K Hold
41
– – ﹤0.01% 701
2025
Q2 		$8.97K Buy
+41
New +$8.77K ﹤0.01% 727
2018
Q1 		– Sell
-17,954
Closed -$1.77M – 306
2017
Q4 		$1.77M Sell
17,954
-1,881
-9% -$184K 0.25% 123
2017
Q3 		$1.91M Sell
19,835
-20,937
-51% -$1.89M 0.29% 110
2017
Q2 		$3.85M Buy
40,772
+11
+0% +$1.01K 0.61% 40
2017
Q1 		$3.33M Buy
40,761
+437
+1% +$36.5K 0.57% 43
2016
Q4 		$3.42M Buy
40,324
+1,114
+3% +$87.6K 0.64% 34
2016
Q3 		$2.92M Buy
39,210
+966
+3% +$76.7K 0.6% 39
2016
Q2 		$2.9M Sell
38,244
-592
-2% -$43.1K 0.63% 37
2016
Q1 		$2.69M Buy
38,836
+594
+2% +$35.7K 0.61% 38
2015
Q4 		$2.3M Buy
38,242
+1,031
+3% +$62K 0.56% 44
2015
Q3 		$2.01M Buy
37,211
+2,069
+6% +$121K 0.52% 52
2015
Q2 		$2.1M Buy
35,142
+3,805
+12% +$212K 0.52% 47
2015
Q1 		$1.89M Buy
31,337
+1,165
+4% +$62.1K 0.49% 47
2014
Q4 		$1.61M Buy
30,172
+5
+0% +$250 0.44% 52
2014
Q3 		$1.35M Buy
30,167
+1,266
+4% +$53.8K 0.4% 61
2014
Q2 		$1.22M Buy
28,901
+1,326
+5% +$56.8K 0.36% 68
2014
Q1 		$1.22M Buy
27,575
+3
+0% +$141 0.39% 54
2013
Q4 		$1.35M Sell
27,572
-152
-0.5% -$7.11K 0.45% 44
2013
Q3 		$1.14M Buy
27,724
+492
+2% +$18.8K 0.41% 48
2013
Q2 		$957K Buy
+27,232
New +$896K 0.38% 58

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

GHP Investment Advisors's WST Position: Q2 2026 in Review

GHP Investment Advisors held its West Pharmaceutical (WST) position steady in Q2 2026 at 41 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #758.

GHP Investment Advisors first reported a position in WST in Q2 2013 and has held it in 24 quarters since. The position peaked at $3.85M in Q2 2017. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • GHP Investment Advisors held 41 shares of West Pharmaceutical worth $14.7K as of Q2 2026.
  • GHP Investment Advisors left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of GHP Investment Advisors's portfolio in Q2 2026, its #758 holding.
  • GHP Investment Advisors first reported a position in West Pharmaceutical in Q2 2013 and has held it in 24 quarters since.
  • GHP Investment Advisors's West Pharmaceutical position peaked at $3.85M in Q2 2017.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.